We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
77 ELEKTRONIKA

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Off-The-Shelf Surgical Device to Help Avoid Total Knee Replacement

By HospiMedica International staff writers
Posted on 03 Jun 2024
Print article
Image: A synthetic cartilage-capped regenerative osteochondral plug being implanted into a knee (Photo courtesy of Texas A&M Engineering)
Image: A synthetic cartilage-capped regenerative osteochondral plug being implanted into a knee (Photo courtesy of Texas A&M Engineering)

Osteochondral defects (OCDs) lead to damage in both cartilage and the underlying bone, often resulting in chronic pain and a loss of joint function. Treatment options vary depending on the severity of the damage and typically include autografting or total knee replacement. Autografting involves harvesting small cylindrical specimens from unaffected areas of the knee and implanting them into the damaged area. This method may be less effective in patients over 40 or those with large defects. When autografting is unsuitable, patients may require a total knee replacement, an extensive procedure where damaged knee components are replaced with a metal and plastic prosthetic. Although often necessary, this surgery can lead to various post-operative complications. To address these challenges, researchers have now developed synthetic cartilage-capped regenerative osteochondral plugs (CC-ROPs), a promising off-the-shelf surgical device to potentially avoid total knee replacements.

These CC-ROPs, created by researchers at Texas A&M University (College Station, TX, USA), are composed of two elements: a cartilage cap and an osseous (bone) base. The cartilage cap is made from an ultra-strong hydrogel that effectively replicates the mechanical attributes of natural cartilage, while the base consists of a porous, bioresorbable polymer. Once the CC-ROP is implanted, the bone base is gradually replaced by new bone tissue, helping to secure the cartilage cap and promote the integration of the implant with the existing bone, thus maintaining necessary joint function. The design of the CC-ROPs is such that they are not limited by the patient's age or defect size.

Additionally, these plugs are shaped like traditional cylindrical autografts, allowing them to be inserted using standard surgical tools and techniques. They do not need to be pre-loaded with cells or growth factors to facilitate healing, relying instead on the inherent properties of the cap and base to aid recovery. Upon implantation, the CC-ROP immediately supports joint function, including movements like knee articulation. The research team is focused on enhancing the therapeutic potential of these devices, conducting rigorous analyses to verify their functionality and readiness for clinical use. They are also planning to assess the efficacy of the CC-ROPs in pre-clinical trials.

“Chronic knee pain and disability are caused by cartilage loss and OCDs stemming from arthritis, including osteoarthritis and post-traumatic arthritis causing individuals pain that limits comfort and mobility,” said Dr. Melissa Grunlan, professor in the Department of Biomedical Engineering at Texas A&M University. “Overall, this design represents a feasible approach for clinical translation.”

Related Links:
Texas A&M University

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Orthopedic Extension
AMSCO

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.